Comparison of Effectiveness of Mask Ventilation and Endotracheal Tube in Pharynx (TTIP) in Patients With Potential Difficult Airway

Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Recruiting
CT.gov ID
NCT05005390
Collaborator
(none)
245
1
2
6.2
39.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the efficacy of TTIP-first ventilation and to compare the efficacy of TTIP first ventilation with the current practice of mask-first ventilation

Condition or Disease Intervention/Treatment Phase
  • Device: TTIP ventilation then mask ventilation
  • Device: Mask Ventilation then TTIP ventilation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
245 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Effectiveness of Mask Ventilation and Endotracheal Tube in Pharynx (TTIP) in Patients With Potential Difficult Airway:A Prospective Randomized and Blinded Trial.
Actual Study Start Date :
Jul 26, 2021
Anticipated Primary Completion Date :
Jan 31, 2022
Anticipated Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group A (TTIP ventilation then mask ventilation )

Subjects will first be ventilated with the TTIP technique. If the subjects are adequately ventilated, as defined by carbon dioxide measured during exhalation in at least one of the first three consecutive breaths, ventilation will continue until completion of 10 breaths, for 1 min (Step 1).Subjects will then be ventilated with mask ventilation (Step 2).In Step 1, if ventilation fails with the TTIP technique for all of the first three consecutive breaths, the subject will be crossed over to the mask ventilation. If ventilation fails again with all the first three consecutive breaths after crossover,the study will be terminated.The routine care is resumed including tracheal intubation or laryngeal mask airway (LMA) insertion.

Device: TTIP ventilation then mask ventilation
In TTIP ventilation, an endotracheal tube is inserted via the nostril or oral cavity and subsequently advanced until the tip of the tube reaches approximately the level of the glottis.

Active Comparator: Group B (mask ventilation, then TTIP ventilation)

Subjects will first be ventilated with the mask technique. If the subjects are adequately ventilated, as defined by carbon dioxide measured during exhalation in at least one of the first three consecutive breaths, ventilation will continue until completion of 10 breaths, for 1 min (Step 1).Subjects will then be ventilated with TTIP technique (Step 2).In Step 1, if ventilation fails for all of the first three consecutive breaths, the subject will be crossed over to the TTIP ventilation. If ventilation fails again with all the first three consecutive breaths after crossover,the study will be terminated.The routine care is resumed including tracheal intubation or LMA insertion.

Device: Mask Ventilation then TTIP ventilation
In mask ventilation, a mask is placed over the nose and mouth.

Outcome Measures

Primary Outcome Measures

  1. Number of patients with successful ventilation [Baseline before start of surgery]

    successful ventilation is defined when atleast one of the first three breaths shows three phases of expired Carbon dioxide(CO2) profile.

  2. Number of patients with successful ventilation [end of surgery (about 1 hour after start)]

    successful ventilation is defined when atleast one of the first three breaths shows three phases of expired CO2 profile.

Secondary Outcome Measures

  1. Change in Expired tidal volume of ventilation [Baseline before start of surgery,end of surgery (about 1 hour after start)]

    This is measured by readings from the ventilator used in the operating room

  2. Peak inspiratory airway pressure achieved [Baseline before start of surgery]

    This is measured by readings from the ventilator used in the operating room

  3. Peak inspiratory airway pressure achieved [end of surgery (about 1 hour after start)]

    This is measured by readings from the ventilator used in the operating room

  4. Dynamic airway resistance [Baseline before start of surgery]

    This is defined as the peak inspiratory flow divided by the corresponding airway pressure.

  5. Dynamic airway resistance [end of surgery (about 1 hour after start)]

    This is defined as the peak inspiratory flow divided by the corresponding airway pressure.

  6. Satisfaction of the providers obtained with post ventilation survey [Baseline before start of surgery]

  7. Satisfaction of the providers obtained with post ventilation survey [end of surgery (about 1 hour after start)]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • BMI >30 kg/m2

  • Mallampati class III or IV

  • Requiring general anesthesia

Exclusion Criteria:
  • Acute and chronic respiratory disorders, including Chronic obstructive pulmonary disease(COPD)and asthma

  • American Society of Anesthesiologists (ASA)physical status classification ≥IV

  • Emergency surgery

  • Induction requiring rapid sequence for intubation

  • Patients requiring awake intubation

  • Pregnant women

  • Untreated ischemic heart disease

  • Contraindication for mask ventilation

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Texas Health Science Center at Houston Houston Texas United States 77030

Sponsors and Collaborators

  • The University of Texas Health Science Center, Houston

Investigators

  • Principal Investigator: Travis Markham, MD, The University of Texas Health Science Center, Houston

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Travis Markham, Assistant Professor, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT05005390
Other Study ID Numbers:
  • HSC-MS-21-0478
First Posted:
Aug 13, 2021
Last Update Posted:
Dec 20, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Travis Markham, Assistant Professor, The University of Texas Health Science Center, Houston

Study Results

No Results Posted as of Dec 20, 2021